Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yibo, Zheng, Junping, Yuan, Xubing, Jiao, Siming, Feng, Cui, Du, Yuguang, Liu, Hongtao, Zheng, Lanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265870/
https://www.ncbi.nlm.nih.gov/pubmed/30463189
http://dx.doi.org/10.3390/md16110455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265870/
https://www.ncbi.nlm.nih.gov/pubmed/30463189
http://dx.doi.org/10.3390/md16110455

Ejemplares similares